Table 2. pVL levels at 4 weeks after ART stop by PHI versus chronically-infected participants.

pVL, copies/ml	Chronic HIV infection	PHI (SPARTAC) N = 156*
	(SMART) N = 1327*
<400	284 (21%)	35 (22%)
400–3499	161 (12%)	34 (22%)
3500–9999	110 (8%)	36 (23%)
10,000–49,999	235 (18%)	25 (16%)
≥50,000	537 (40%)	26 (17%)

Values are n (%). pVL = plasma viral load.

Adjusted p-value from ordered logistic regression <0.001.

^*Of participants with a week 4 pVL available.